Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

ClinicalTrials.gov ID: NCT03650114

Public ClinicalTrials.gov record NCT03650114. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Single Arm, Multi-center Extension Study Evaluating Long-term Safety, Tolerability and Effectiveness of Ofatumumab in Subjects With Relapsing Multiple Sclerosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS). COVID-19 sub-study: The purpose of this research sub-study is to explore the immune response following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination in a subset of subjects on long-term ofatumumab 20 mg sc. Note: Novartis is not supplying the SARS-CoV-2 vaccine.

Study identification

NCT ID
NCT03650114
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
1,882 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 28, 2018 (Actual)
Primary completion
Sep 30, 2028 (Estimated)
Completion
Sep 30, 2028 (Estimated)
Last update posted
May 27, 2026

2018 – 2028

United States locations

U.S. sites
86
U.S. states
32
U.S. cities
77
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233-0271 —
North Central Neurology Associates PC Cullman Alabama 35058 —
Barrow Neurological Clinics at St Josephs Hospital and MC Phoenix Arizona 85013 —
Fullerton Neuro and Headache Ctr Fullerton California 92835 —
University of California Davis Sacramento California 95817 —
CU Anschutz Med Campus Aurora Colorado 80045 —
Mountain Neuro Research Center PC Basalt Colorado 81621 —
Alpine Clinical Research Center Boulder Colorado 80301 —
Colorado Springs Neurological Associates Colorado Springs Colorado 80907 —
Colorado Neurological Research PC Denver Colorado 80210 —
University of Colorado Health Neurology Fort Collins Colorado 80528 —
Christiana Care Health Services Newark Delaware 19713 —
Jem Research Institute Atlantis Florida 33462-6608 —
Neurology Offices of South Florida PLLC Delray Beach Florida 33445 —
Infinity Clinical Research LLC Hollywood Florida 33024 —
Homestead Assoc In Research Inc Homestead Florida 33033 —
Neurology Associates PA Maitland Florida 32751 —
UM Department Of Neurology Miami Florida 33136 —
Aqualane Clinical Research Naples Florida 34105 —
MS and Neuromuscular Center of Excellence Oldsmar Florida 34677 —
Neurology Associates of Ormond Beach Ormond Beach Florida 32174 —
Emerald Coast Neurology Pensacola Florida 32514 —
Neurostudies Inc Port Charlotte Florida 33952 —
Negroski Neurology Sarasota Florida 34233 —
Roskamp Institute Inc Sarasota Florida 34243 —
AMO Corporation Tallahassee Florida 32312 —
Clinical Research of West Florida Inc Tampa Florida 33606 —
Axiom Clinical Research of Florida Tampa Florida 33609 —
University Of South Florida Tampa Florida 33612 —
Premiere Research Institute West Palm Beach Florida 33407 —
Velocity Clinical Research Savannah Georgia 31406 —
Georgia Neurology and Sleep Medicine Assoc Suwanee Georgia 30024 —
Hawaii Pacific Neuroscience LLC Honolulu Hawaii 96817 —
Rush University Medical Center Chicago Illinois 60612 —
Consultants in Neurology Northbrook Illinois 60062 —
Josephson Wallack Munshower Neurology PC Indianapolis Indiana 46256 —
University of Kansas Hospital Kansas City Kansas 66160 —
College Park Family Care Center Overland Park Kansas 66210 —
Neuro Medical Clinic of Cenla LLC Alexandria Louisiana 71301 —
The Neuromedical Center Baton Rouge Louisiana 70810 —
Dragonfly Research LLC Wellesley Hills Massachusetts 02481 —
Wayne State University Multiple Sclerosis Clinic Detroit Michigan 48201 —
Henry Ford Hospital Detroit Michigan 48202-2689 —
Vivo Infusion Plymouth Minnesota 55446 —
Sharlin Health and Neurology Ozark Missouri 65721 —
WA Uni School Of Med St Louis Missouri 63110 —
Mercy Research St Louis Missouri 63141 —
Billings Clinic Billings Montana 59101 —
Advanced Neurology Specialists Great Falls Montana 59405 —
Cleveland Clinic Foundation Las Vegas Nevada 89106 —
University of New Mexico Albuquerque New Mexico 87131-0001 —
Ms Ctr Of Northeastern Ny Latham New York 12110 —
Asheville Neurology Specialists PA Asheville North Carolina 28806 —
The Neurological Institute PA Charlotte North Carolina 28204 —
Guilford Neurologic Associate Research Greensboro North Carolina 27405 —
Velocity Clinical Research Raleigh North Carolina 27607 —
PMG Research of Winston Salem Winston-Salem North Carolina 27103 —
Neurology and Neuroscience Assos Akron Ohio 44320 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Ohio Health Research Institute Columbus Ohio 43214 —
Columbus Neuroscience Westerville Ohio 43082 —
Multiple Sclerosis Center of Excellence of OMRF Oklahoma City Oklahoma 73104 —
Providence Neurological Services West Portland Oregon 97225 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107-5098 —
Abington Neurological Associates Ltd Willow Grove Pennsylvania 19090 —
Premier Neurology Greenville South Carolina 29605 —
BG Neurology Spartanburg South Carolina 29303 —
Upstate Clinical Trials LLC Spartanburg South Carolina 29303 —
Wesley Neurology Clinic Cordova Tennessee 38018 —
Tri State Mountain Neurology Johnson Tennessee 37604 —
University of Tennessee Medical Ctr Knoxville Tennessee 37920 —
Sibyl Wray MD Neurology PC Knoxville Tennessee 37922 —
Med Research Inc El Paso Texas 79935 —
Neurology and Sleep Center Lubbock Texas 79410 —
Central TX Neuro Consultants P A Round Rock Texas 78681 —
Lonestar Neurology of San Antonio San Antonio Texas 78258 —
Texas Institute for Neurological Disorders Sherman Texas 75092 —
Rocky Mountain MS Clinic Salt Lake City Utah 84103 —
The University of Utah Salt Lake City Utah 84132-0001 —
Sentara Neuroscience Institute Virginia Beach Virginia 23456 —
Evergreen Health Multiple Sclerosis Center Kirkland Washington 98034 —
MultiCare Research Institute for Research and Innovation Tacoma Washington 98405 —
Aurora BayCare Medical Center Green Bay Wisconsin 54311 —
University of Wisconsin Madison Madison Wisconsin 53792 —
Ascension St Francis Center Milwaukee Wisconsin 53215 —
St Luke s Medical Center Aurora Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 209 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03650114, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 27, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03650114 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →